Robert S. Landsman

Array ( [id] => 7767848 [patent_doc_number] => 20120035106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'USE OF APL-TYPE PEPTIDE FOR TREATING INTESTINAL INFLAMMATORY DISEASES AND TYPE 1 DIABETES' [patent_app_type] => utility [patent_app_number] => 13/142471 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5784 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035106.pdf [firstpage_image] =>[orig_patent_app_number] => 13142471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087712 [patent_doc_number] => 20110217232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Method for Determination of the Responsiveness of an Individual to Misletoe Lectin' [patent_app_type] => utility [patent_app_number] => 12/643857 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17822 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217232.pdf [firstpage_image] =>[orig_patent_app_number] => 12643857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663603 [patent_doc_number] => 20110312872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'NORRIN IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN INCREASED TGF-BETA ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/141047 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312872.pdf [firstpage_image] =>[orig_patent_app_number] => 13141047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421791 [patent_doc_number] => 08278279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Method for treating prostatitis utilizing modified pore-forming protein proaerolysin' [patent_app_type] => utility [patent_app_number] => 13/139928 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19188 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10115787 [patent_doc_number] => 09150658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Human antibodies against tissue factor and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/133811 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 23 [patent_no_of_words] => 40775 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283044 [patent_doc_number] => 08217146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Neurotrophic factors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/632517 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 31605 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12632517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624089 [patent_doc_number] => 08003384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Cell lines comprising sour-taste receptors' [patent_app_type] => utility [patent_app_number] => 12/632299 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8716 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003384.pdf [firstpage_image] =>[orig_patent_app_number] => 12632299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797268 [patent_doc_number] => 08436137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide' [patent_app_type] => utility [patent_app_number] => 13/132580 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 81 [patent_no_of_words] => 39190 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670069 [patent_doc_number] => 20110319338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'PEPTIDES THAT BIND EUKARYOTIC TRANSLATION INITIATION FACTOR 4E' [patent_app_type] => utility [patent_app_number] => 13/140722 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19613 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9711033 [patent_doc_number] => 08835603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Agents for the treatment of celiac disease' [patent_app_type] => utility [patent_app_number] => 13/131787 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 33411 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596878 [patent_doc_number] => 20100292151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'USE OF HUMAN CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/620059 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61375 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292151.pdf [firstpage_image] =>[orig_patent_app_number] => 12620059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588856 [patent_doc_number] => 20100061999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'ANTIHUMAN TNF-ALPHA ANTIBODY ACTIVITY LOWERING INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/620191 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5371 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061999.pdf [firstpage_image] =>[orig_patent_app_number] => 12620191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423778 [patent_doc_number] => 20100168014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Screening method' [patent_app_type] => utility [patent_app_number] => 12/591105 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26804 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168014.pdf [firstpage_image] =>[orig_patent_app_number] => 12591105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487483 [patent_doc_number] => 20110236397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF RENAL DISEASE' [patent_app_type] => utility [patent_app_number] => 13/127839 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24294 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236397.pdf [firstpage_image] =>[orig_patent_app_number] => 13127839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6322977 [patent_doc_number] => 20100113748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'SOLUBLE IL-17RCX4 AND METHODS OF USING IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/580112 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60380 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113748.pdf [firstpage_image] =>[orig_patent_app_number] => 12580112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566871 [patent_doc_number] => 20110286934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'MEMBRANE TRANSDUCTION PEPTIDES, POLYNUCLEOTIDES, AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/129942 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11681 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20110286934.pdf [firstpage_image] =>[orig_patent_app_number] => 13129942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488513 [patent_doc_number] => 20110236893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'LGR5 MODULATORS IN THE TREATMENT OF ALOPECIA' [patent_app_type] => utility [patent_app_number] => 13/120104 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5229 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236893.pdf [firstpage_image] =>[orig_patent_app_number] => 13120104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4531250 [patent_doc_number] => 07871631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Methods of inhibiting the lowering of antihuman TNF-α antibody' [patent_app_type] => utility [patent_app_number] => 12/562728 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5448 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871631.pdf [firstpage_image] =>[orig_patent_app_number] => 12562728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487441 [patent_doc_number] => 20110251126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'INTESTINAL TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/062932 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10135 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251126.pdf [firstpage_image] =>[orig_patent_app_number] => 13062932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294424 [patent_doc_number] => 08222210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Methods of using substance P to promote healing of vascular wounds' [patent_app_type] => utility [patent_app_number] => 12/556402 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 10 [patent_no_of_words] => 16577 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12556402 [rel_patent_id] =>[rel_patent_doc_number] =>)